In the first four months of 2026, OpenAI has rolled out a series of healthcare-focused products and announcements, including a consumer health feature, a suite of hospital tools, a clinician-facing offering, a biology research model and an acquisition of a health data startup.
Here is a look at OpenAI’s biggest healthcare moves, as reported by Becker’s since January:
January
- OpenAI rolled out ChatGPT Health, a new feature that allows users to securely integrate personal health information with ChatGPT’s AI to better understand and manage health-related questions.
- OpenAI-led research released in January found that more than 40 million Americans use ChatGPT daily to ask questions about healthcare.
- OpenAI launched OpenAI for Healthcare, a suite of AI products aimed at supporting clinical and administrative work at hospitals and health systems. The launch included ChatGPT for Healthcare and the OpenAI API for Healthcare.
- The company also announced that it would be acquiring Torch, a healthcare startup focused on unifying lab results, medication data and visit recordings.
April
- OpenAI introduced a new advanced AI model, GPT-Rosalind, to support research into biology, drug discovery and translational medicine.
- OpenAI launched ChatGPT for Clinicians, a new tool designed to support healthcare professionals with tasks such as clinical documentation, drafting written materials and conducting medical research. The offering is available at no cost to verified U.S.-based physicians, nurse practitioners, physician assistants and pharmacists.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.